AUSTIN, TX (February 11, 2025)—Prodigy Health is honored to announce Fei Li’s appointment to its Board of Directors. Ms. Li brings remarkable experience in private equity and investment banking, having held leadership roles at Cerberus Capital Management, Evercore, and J.P. Morgan. Throughout her distinguished career, Ms. Li has developed expertise in capital management, mergers and acquisitions, and strategic financial growth.
Ms. Li’s innovative approach to financial strategy and her proven ability to navigate complex market landscapes make her a valuable addition to Prodigy Health’s leadership. Her insights will contribute to the company’s progress as a champion of specialty drug distribution nationwide.
As Prodigy Health continues to expand its impact, Ms. Li’s appointment highlights its commitment to fostering transformative leadership and maintaining its position as a trailblazer in healthcare supply chain solutions. Her strategic vision and deep understanding of data-driven decision-making will help Prodigy Health enhance its efficiency, reliability, and customer-focused service.
“I am truly excited to join the Board of Directors at Prodigy Health. I look forward to working with such a dedicated and talented team,” said Ms. Li of her new position. “We believe that Prodigy’s market position, customer-centric approach, and innovative technology infrastructure provide a solid foundation for the company’s next growth phase.”
The addition of Fei Li marks an exciting milestone for Prodigy Health and reinforces its dedication to innovation and excellence in the healthcare industry.
